NGMedical announced first U.S. operations using its purely additively manufactured titanium cervical BEE® cage.
The BEE cage is designed to challenge the limits of additive manufacturing. The purposefully designed honeycomb endplate design reduces the risk of subsidence, while allowing fusion. The honeycomb structure allows for bony ingrowth and demonstrates the reduced use of titanium minimizing risks of x-ray artefacts, while offering a very large graft space. This is another significant innovation from the team, who invented the first line of additively manufactured interbody devices.
“This successful market launch in the USA is an important step for NGMedical. The first operations in this important market are a great achievement in our international commercialization. BEE is our first implant available in the USA to be followed by further innovations shortly,” said Peter Weiland, CEO of NGMedical.
NGMedical announced first U.S. operations using its purely additively manufactured titanium cervical BEE® cage.
The BEE cage is designed to challenge the limits of additive manufacturing. The purposefully designed honeycomb endplate design reduces the risk of subsidence, while allowing fusion. The honeycomb structure allows for bony ingrowth...
NGMedical announced first U.S. operations using its purely additively manufactured titanium cervical BEE® cage.
The BEE cage is designed to challenge the limits of additive manufacturing. The purposefully designed honeycomb endplate design reduces the risk of subsidence, while allowing fusion. The honeycomb structure allows for bony ingrowth and demonstrates the reduced use of titanium minimizing risks of x-ray artefacts, while offering a very large graft space. This is another significant innovation from the team, who invented the first line of additively manufactured interbody devices.
“This successful market launch in the USA is an important step for NGMedical. The first operations in this important market are a great achievement in our international commercialization. BEE is our first implant available in the USA to be followed by further innovations shortly,” said Peter Weiland, CEO of NGMedical.
Copy to clipboard 
